Mechanism of action of disease modifying anti-rheumatic agent, gold sodium thiomalate (GSTM). (Q43640818)

25 November 2017

title

Mechanism of action of disease modifying anti-rheumatic agent, gold sodium thiomalate (GSTM). (English)

1 reference

25 November 2017

Mangalam AK

1 reference

25 November 2017

Aggarwal A

series ordinal

1 reference

25 November 2017

Naik S

series ordinal

1 reference

25 November 2017

publication date

1 June 2001

1 reference

International Immunopharmacology

25 November 2017

published in

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

1165-1172

1 reference

Role of cytokines in rheumatoid arthritis

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Role of pro-inflammatory cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

In vitro effect of gold sodium thiomalate and methotrexate on tumor necrosis factor production in normal healthy individuals and patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Electron-dense deposits following injection of Gold Sodium Thiomalate and Thiomalic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

High-throughput RT-PCR analysis of multiple transcripts using a microplate RNA isolation procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

TNF gene expression in monocytes of low and high responder individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900050-9

7 January 2021

10.1016/S1567-5769(01)00050-9

Identifiers

DOI

1 reference

25 November 2017

1 reference